Menu Search
Equities

Baijin Life Science Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1466:HKG.HZ

Baijin Life Science Holdings Ltd

Actions
  • Price (HKD)0.540
  • Today's Change0.00 / 0.00%
  • Shares traded3.00k
  • 1 Year change+8.00%
  • Beta0.4318
Data delayed at least 15 minutes, as of Feb 16 2026 02:41 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Baijin Life Science Holdings Ltd, formerly Affluent Partners Holdings Ltd, is an investment holding company principally engaged in the manufacture and sale of jewellery products. The Company operates the business through five segments. The Sales of Pearls and Jewellery Products segment is engaged in the design and sale of jewellery products as well as sale of pearls. The Brand marketing and Consulting Services segment is engaged in the provision of brand marketing and consulting services based on contracts with agreed terms of services. The Skincare Solutions Business segment is engaged in the sales of skincare solution products to cosmetic stores and hospitals by sales contracts as well as individuals via online sales platforms, under the brand name FO. The Research and Development Services segment is engaged in the Provision of professional scientific services. The Strategic Investment and Financial Services segment is engaged in the real estate financial assets investment.

  • Revenue in HKD (TTM)119.80m
  • Net income in HKD8.08m
  • Incorporated2014
  • Employees79.00
  • Location
    Baijin Life Science Holdings LtdSuites 2208-14, 22nd Floor, Sun Life TwrThe Gateway, 15 Canton RoadTsimshatsui, Kowloon Hong KongHKG
  • Phone+852 36112188
  • Fax+852 35946110
  • Websitehttps://www.baijinlifescience.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.